Oslo, Norway, 3 October 2016
Vistin Pharma ASA (OSE: VISTIN) is giving a number of investor presentations following the release of its financial report for the second quarter 2016. Please find attached an updated corporate presentation used for this purpose, which has also been made available on www.vistin.com.
For further information, please contact:
Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
